Ignite Creation Date:
2025-12-24 @ 3:04 PM
Ignite Modification Date:
2026-03-18 @ 3:47 AM
Study NCT ID:
NCT03185559
Status:
TERMINATED
Last Update Posted:
2018-03-29
First Post:
2017-06-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized, Double-blind Clinical Investigation to Evaluate the Use of the Relievion™ Device in Treating Migraine.
Sponsor:
Neurolief Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NRLF-0038-17-MMC-CTIL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None